These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23123053)

  • 1. Regulation of the brain-gut axis by group III metabotropic glutamate receptors.
    Julio-Pieper M; O'Connor RM; Dinan TG; Cryan JF
    Eur J Pharmacol; 2013 Jan; 698(1-3):19-30. PubMed ID: 23123053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues.
    Julio-Pieper M; Flor PJ; Dinan TG; Cryan JF
    Pharmacol Rev; 2011 Mar; 63(1):35-58. PubMed ID: 21228260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptors and the control of chronic pain.
    Chiechio S; Nicoletti F
    Curr Opin Pharmacol; 2012 Feb; 12(1):28-34. PubMed ID: 22040745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.
    Swanson CJ; Bures M; Johnson MP; Linden AM; Monn JA; Schoepp DD
    Nat Rev Drug Discov; 2005 Feb; 4(2):131-44. PubMed ID: 15665858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
    O'Connor RM; Finger BC; Flor PJ; Cryan JF
    Eur J Pharmacol; 2010 Aug; 639(1-3):123-31. PubMed ID: 20371242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
    Lesage A; Steckler T
    Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.
    Chaki S
    Eur J Pharmacol; 2010 Aug; 639(1-3):59-66. PubMed ID: 20371240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
    Luján-Miras R
    Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
    Spooren W; Ballard T; Gasparini F; Amalric M; Mutel V; Schreiber R
    Behav Pharmacol; 2003 Jul; 14(4):257-77. PubMed ID: 12838033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic glutamate receptors: beyond the regulation of synaptic transmission.
    Nicoletti F; Battaglia G; Storto M; Ngomba RT; Iacovelli L; Arcella A; Gradini R; Sale P; Rampello L; De Vita T; Di Marco R; Melchiorri D; Bruno V
    Psychoneuroendocrinology; 2007 Aug; 32 Suppl 1():S40-5. PubMed ID: 17651904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood disorders: regulation by metabotropic glutamate receptors.
    Pilc A; Chaki S; Nowak G; Witkin JM
    Biochem Pharmacol; 2008 Mar; 75(5):997-1006. PubMed ID: 18164691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
    Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition.
    Marek GJ
    Eur J Pharmacol; 2010 Aug; 639(1-3):81-90. PubMed ID: 20371229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
    Pitsikas N
    Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical evidence for the differential association of metabotropic glutamate receptors within synaptic complexes.
    Asuni AA; Lidwell K; O'Connor V
    Neurosci Lett; 2008 Oct; 444(1):27-30. PubMed ID: 18706475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptors: new targets for the control of tumor growth?
    Nicoletti F; Arcella A; Iacovelli L; Battaglia G; Giangaspero F; Melchiorri D
    Trends Pharmacol Sci; 2007 May; 28(5):206-13. PubMed ID: 17433452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.
    Schoepp DD
    J Pharmacol Exp Ther; 2001 Oct; 299(1):12-20. PubMed ID: 11561058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.